J P Hancock
Overview
Explore the profile of J P Hancock including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
108
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hancock J, Goulden N, Oakhill A, Steward C
Leukemia
. 2003 Jan;
17(1):247-51.
PMID: 12529688
No abstract available.
2.
Garland R, West S, Hancock J, Goulden N, Steward C, Rowbottom A
Scand J Immunol
. 2002 Feb;
55(1):61-9.
PMID: 11841693
Cytotoxic T lymphocytes (CTL) are important for the recognition and lysis of virally infected cells, but their effectiveness can be limited by viral immune evasion mechanisms. We investigated the immunophenotype...
3.
Garland R, Kaneria S, Hancock J, Steward C, Rowbottom A
J Immunol Methods
. 1999 Sep;
227(1-2):53-63.
PMID: 10485254
We have investigated the ability of Teflon cell culture (TCC) bags, compared to conventional tissue culture flasks and plates, to support the expansion of human CD8+ T cells in response...
4.
Knechtli C, Goulden N, Hancock J, Grandage V, Harris E, Garland R, et al.
Blood
. 1998 Dec;
92(11):4072-9.
PMID: 9834212
The efficacy of allografting in acute lymphoblastic leukemia (ALL) is heavily influenced by remission status at the time of transplant. Using polymerase chain reaction (PCR)-based minimal residual disease (MRD) analysis,...
5.
Knechtli C, Goulden N, Hancock J, Harris E, Garland R, Jones C, et al.
Br J Haematol
. 1998 Aug;
102(3):860-71.
PMID: 9722317
We have analysed the behaviour of minimal residual disease (MRD) after allogeneic bone marrow transplantation (allo-BMT) in 71 children with acute lymphoblastic leukaemia (ALL). The method relied on PCR of...
6.
Goulden N, Knechtli C, Garland R, Langlands K, Hancock J, Potter M, et al.
Br J Haematol
. 1998 Feb;
100(1):235-44.
PMID: 9450818
We report a largely retrospective analysis of minimal residual disease (MRD) in a cohort of 66 children suffering from acute lymphoblastic leukaemia (ALL). All patients lacked high-risk features at diagnosis,...
7.
Hancock J, Burgess M, Goulden N, Steward C, Knechtli C, Pamphilon D, et al.
Br J Haematol
. 1997 Dec;
99(2):403-9.
PMID: 9375762
The accurate and rapid determination of the origin of haemopoietic cells may provide valuable information as to the aetiology of, and most appropriate therapy for, leucopenia following allogeneic bone marrow...
8.
Kemshead J, Hancock J, Liberti P
Prog Clin Biol Res
. 1994 Jan;
389:593-600.
PMID: 7700925
No abstract available.
9.
Hancock J, Kemshead J
J Immunol Methods
. 1993 Aug;
164(1):51-60.
PMID: 7689621
Immunomagnetic colloids have the properties of solutions and, therefore, offer distinct advantages in their ability to bind to cells as compared to larger magnetic microspheres. B cells and T cells...
10.
Lashford L, Hancock J, Kemshead J
Int J Cancer
. 1991 Jan;
47(1):105-9.
PMID: 1985865
Whilst many human neuroblastoma cell lines have been studied to see if they are capable of taking up mIBG, few appear to have this ability. This contrasts markedly to the...